24 October 2024
Following our successful Advanced Therapies event in October, Deloitte – with input from MEDVIA and BioWin – has produced a white paper on advanced therapeutic medicinal products (ATMPs) in Belgium. This paper is a reflection on the field and the challenges and opportunities of these therapies for the Belgian ecosystem.
Rapid scientific advancements are expanding the use of advanced therapies beyond rare diseases, making them more accessible and affordable in clinical practice. However, scaling these innovations requires a mature and well-funded ecosystem that supports the entire value chain – from innovation in manufacturing and logistics to talent development.
Belgium has the strategic location, specialized infrastructure, academic excellence and innovative healthcare system to become Europe’s biomanufacturing gateway!
